EPA:EMEIS - Euronext Paris - Matif - FR001400NLM4 - Common Stock - Currency: EUR
EPA:EMEIS (3/7/2025, 7:00:00 PM)
12.234
+0.22 (+1.8%)
The current stock price of EMEIS.PA is 12.234 EUR. In the past month the price increased by 55.59%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CLARI.PA | CLARIANE SE | N/A | 1.32B | ||
GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 1.15B | ||
RHK.DE | RHOEN-KLINIKUM AG | 19.25 | 863.78M | ||
GHC.MI | GAROFALO HEALTH CARE SPA | 13.08 | 448.29M | ||
M12.DE | M1 KLINIKEN AG | 17.41 | 290.67M | ||
LNA.PA | LNA SANTE | 11.32 | 283.81M | ||
MED.DE | MEDICLIN AG | N/A | 136.80M | ||
LIK.DE | LIMES SCHLOSSKLINIKEN AG | N/A | 83.52M | ||
EIF.DE | MEDNATION AG | 1.32 | 4.21M |
Emeis SA is a FR-based company operating in Health Care Providers & Services industry. The company is headquartered in Puteaux, Ile-De-France and currently employs 78,476 full-time employees. The company went IPO on 2002-04-16. Orpea SA is a France-based company that is engaged in the operations of retirement homes, outpatient and rehabilitation clinics, and psychiatric care. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services, and long-term care homes. The firm operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. The company operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.
EMEIS SA
12 Rue Jean Jaures, Puteaux Cedex
Puteaux ILE-DE-FRANCE FR
Employees: 78476
Company Website: https://www.emeis.fr/
Investor Relations: http://www.orpea-corp.com/index.php/actionnaire-menu/bourse
Phone: 33140781515
The current stock price of EMEIS.PA is 12.234 EUR. The price increased by 1.8% in the last trading session.
The exchange symbol of EMEIS SA is EMEIS and it is listed on the Euronext Paris - Matif exchange.
EMEIS.PA stock is listed on the Euronext Paris - Matif exchange.
11 analysts have analysed EMEIS.PA and the average price target is 10.2 EUR. This implies a price decrease of -16.63% is expected in the next year compared to the current price of 12.234. Check the EMEIS SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
EMEIS SA (EMEIS.PA) has a market capitalization of 1.98B EUR. This makes EMEIS.PA a Small Cap stock.
EMEIS SA (EMEIS.PA) currently has 78476 employees.
The Revenue of EMEIS SA (EMEIS.PA) is expected to grow by 8.21% in the next year. Check the estimates tab for more information on the EMEIS.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EMEIS.PA does not pay a dividend.
EMEIS SA (EMEIS.PA) will report earnings on 2025-05-12.
The PE ratio for EMEIS SA (EMEIS.PA) is 2.49. This is based on the reported non-GAAP earnings per share of 4.92 and the current share price of 12.234 EUR. Check the full fundamental report for a full analysis of the valuation metrics for EMEIS.PA.
ChartMill assigns a technical rating of 7 / 10 to EMEIS.PA.
ChartMill assigns a fundamental rating of 4 / 10 to EMEIS.PA. EMEIS.PA has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months EMEIS.PA reported a non-GAAP Earnings per Share(EPS) of 4.92. The EPS increased by 220.29% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 27.04% | ||
ROA | 10.61% | ||
ROE | 76.36% | ||
Debt/Equity | 4.15 |
ChartMill assigns a Buy % Consensus number of 80% to EMEIS.PA. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 98.31% and a revenue growth 8.21% for EMEIS.PA